Skip to content

Veradermics Inc MANE Stock Analysis

  • NYSE
  • Stock
  • Market closed · opens Monday 9:30 AM ET

$108.82 down $6.25, 5.43% at close Oct 16

Last close · Previous close $115.07

Market cap
At the Oct 16 close
Dividend yield
NoneLast 12 months

Price chart

$108.82down $6.25, 5.43%Fri, Oct 16 session

Use the left and right arrow keys to move along the chart.

Chart period
IEX trades, regular session · Times in ET
Price data

Trading

At last close

  • Previous close$115.07Oct 15
  • Volume672.94KOct 16 session
  • Avg. volume944.19KLast 21 sessions
  • 52-week range: $32.00 to $136.72; now $108.82
Member SIPC.Low CommissionsLearn More (opens in a new tab)

Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

Performance

Past performance, measured to the Oct 16 close. Total return includes reinvested dividends. Compared with the S&P 500, using SPY.

Return type

MANE beat the S&P 500 in both periods.

MANE total returns compared with the S&P 500
PeriodMANE and S&P 500vs S&P 500
Short term
1M
MANE: up 6.2%
S&P 500: up 1.5%
MANE beat the S&P 500 by 4.7 percentage points
3M
MANE: up 2.8%
S&P 500: up 1.9%
MANE beat the S&P 500 by 0.9 percentage points

All-time high

$130.90

Closing high on . Now 16.9% below that record.

Split-adjusted daily closes since Feb 4, 2026.

Stock splits

MANE hasn’t split since its price history begins in 2026.

Valuation

Financials

Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.

Chart periods

Revenue and net income

Last 12 months, with the change from the 12 months before

Revenue
Not reported
Net income
Not reported
Diluted EPS
Not reported
Last 8 fiscal quarters
Data table
MANE quarterly results
PeriodRevenueNet incomeDiluted EPS
Q4 FY23 (Dec 31, 2023)Not reportedNot reportedNot reported
Q4 FY24 (Dec 31, 2024)$0.00−$6.48M−$8.79
Q1 FY25 (Mar 31, 2025)$0.00−$14.58M−$19.79
Q2 FY25 (Jun 30, 2025)$0.00−$18.01M−$24.19
Q3 FY25 (Sep 30, 2025)Not reportedNot reportedNot reported
Q4 FY25 (Dec 31, 2025)$0.00−$28.21M−$37.70
Q1 FY26 (Mar 31, 2026)$0.00−$30.01M−$1.32
Q2 FY26 (Jun 30, 2026)$0.00−$23.50M−$0.58

Margins

  • Gross —
  • Operating —
  • Net —

The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you

Cash flow

  • Not reportedLast 12 months
  • Operating cash flowNot reportedLast 12 months
  • Capital spendingNot reportedLast 12 months

Shareholder returns

  • Not reportedLast 12 months
  • Dividends paidNot reportedLast 12 months

Balance sheet

  • $819.89MAs of Jun 30, 2026
  • Total debt$428.00KAs of Jun 30, 2026
  • Net cash$819.47MAs of Jun 30, 2026
  • 70.53As of Jun 30, 2026
  • 0.00As of Jun 30, 2026

Financial strength

    About Veradermics Inc

    Veradermics Inc

    Sector
    Healthcare
    Industry
    Biotechnology
    Headquarters
    Connecticut, USA
    Exchange
    NYSE
    Asset type
    Common stock
    Price history since

    MANE news

    MANE stock FAQ

    What is MANE stock’s price today?

    Veradermics (MANE) traded at $108.82 at the close on , down $6.25 (5.43%) from the previous close of $115.07. Over the past 52 weeks it has traded between $32.00 and $136.72.

    Does MANE pay a dividend?

    Veradermics hasn’t paid a dividend in the last twelve months.

    What is MANE’s 52-week high and low?

    Over the past 52 weeks MANE has traded as low as $32.00 and as high as $136.72. At $108.82 at the close on , it is 20.4% below that high and 240.1% above the low.

    What is MANE’s all-time high?

    MANE’s highest closing price was $130.90 on , adjusted for stock splits. At $108.82 at the close on , it is 16.9% below that record.

    Has MANE stock ever split?

    No. MANE hasn’t split since its price history begins in 2026.

    What sector and industry is Veradermics in?

    Veradermics is in the Healthcare sector and the Biotechnology industry, and is headquartered in Connecticut, USA.

    What exchange does MANE trade on?

    Veradermics trades on the NYSE under the ticker symbol MANE. Its price history on this dashboard begins on .

    Member SIPC.Low CommissionsLearn More (opens in a new tab)

    Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

    About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.

    This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).

    The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.

    Contact Ryan

    Get in touch

    Contact Me

    Have a question or want to work together? Fill out the form below and we'll get back to you as soon as possible.

    Contact Form Demo

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.